Summary & Overview
HCPCS M1032: Adult Pharmacotherapy for OUD
HCPCS Level II code M1032 designates services for adults currently receiving pharmacotherapy for oud. This code identifies ongoing medication management encounters focused on maintaining and monitoring pharmacologic treatment for adults engaged in care for oud. Nationally, clear coding supports continuity of care, accurate claims processing, and appropriate service classification for outpatient medication management.
Key payers commonly involved in coverage decisions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, how it is typically used in outpatient settings, and the payer landscape relevant to reimbursement and coverage. The publication includes benchmarks where available, coding and billing considerations, clinical context for pharmacotherapy-based treatment, and any recent policy updates impacting use of the code.
This analysis is intended for national audiences involved in revenue cycle, clinical operations, and policy development who need a practical summary of HCPCS Level II code M1032 and its role in documenting adult pharmacotherapy services for oud.
Billing Code Overview
HCPCS Level II code M1032 describes adults currently taking pharmacotherapy for oud. The service type is medication management / pharmacotherapy monitoring, focused on ongoing prescription treatment for adults. The typical site of service is outpatient ambulatory settings, including clinics and office-based treatment programs where medication management and follow-up visits occur.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 42-year-old adult enrolled in an outpatient substance use treatment program presents for ongoing management of opioid use disorder while maintained on pharmacotherapy (for example buprenorphine or methadone). The visit occurs in an ambulatory behavioral health clinic with a licensed addiction medicine prescriber (physician, nurse practitioner, or physician assistant) and a medical assistant. The workflow includes medication reconciliation, assessment of treatment response and cravings, urine drug testing as indicated, review of side effects and co-occurring medical or psychiatric conditions, documentation of adherence and any counseling or referral actions, and updating the medication dispense plan. Ancillary services such as prior authorization, coordination with a pharmacy for take-home dosing or clinic-administered doses, and scheduling of follow-up or counseling sessions are part of the visit. Typical site of service is an outpatient clinic or office-based opioid treatment setting. The service is billed to support that the adult patient is currently taking pharmacotherapy for opioid use disorder, documenting active medication treatment and related clinical management activities.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work or resources substantially exceed usual for the service (e.g., extended coordination, complex medication management). |